Here are three points:
1. The firm rated EndoChoice shares “overweight.”
2. The 52-week high of the stock is $17.15, while the 52-week low is $3.64.
3. The market cap of the company is $129 million.
More articles on GI/endoscopy:
Surveillance endoscopy improves esophageal cancer outcomes in Barrett’s esophagus patients: 3 insights
Small bowel resection inpatient costs total $28.5k & 7 more statistics
Dr. Maxime Mahe wins 2016 AGA-Athena Troxel Blackburn Award: 4 notes
